SCHEMBL7050809

SCHEMBL7050809

CCCCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.51
BCL2L1 Q07817 1/20 0.51
MCL1 Q07820 1/20 0.51
SMPD1 P17405 1/20 0.47
KAT6A Q92794 3/20 0.46
PSEN1 P49768 4/20 0.44
ALOX5 P09917 2/20 0.44
PTGES O14684 1/20 0.44
PPARG P37231 1/20 0.44
ALDH1A1 P00352 3/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NR4A3 Q92570 1/20 0.43
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
HTT P42858 1/20 0.42
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052815 0.99 MAOB (0.50) MAOBBCL2L1MCL1SMPD1KAT6A
SCHEMBL7047668 0.93 NR4A1 (0.51) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7047717 0.93 SMPD1 (0.50) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7050498 0.92 SMPD1 (0.52) MAOBBCL2L1MCL1SMPD1KAT6A
SCHEMBL7047657 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7076746 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7080208 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7077945 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7077178 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1
SCHEMBL7080258 0.91 SMPD1 (0.53) BCL2L1MCL1SMPD1KAT6AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MAOB 396/4885BCL2L1 1792/4885MCL1 2343/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 MAOB 2736/4885BCL2L1 1489/4885MCL1 3342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.